Their study, published recently in Nature, focuses on what is known as the estrogen receptor, a protein linked in previous research to the development of roughly 70% of all breast tumors.

Figure 1: Nuclear receptor co-regulators modulate the transcriptional potential of estrogen receptor activated by estradiol, SERMs or growth factors. Although we have until now focused upon the AF ...